Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Edesa Biotech
Company

Edesa Biotech

Tracked across 1 events · 12 articles · First seen Aug 19, 2026 · Last active Aug 20, 2026

Sentiment
-20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 -20
Business
Edesa Biotech $25M Public Offering
Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company, announced the pricing of an underwritten public offering of common shares and warrants. The offering consists of 3,870,500 common shares and accompanying warrants to purchase an…
Impact: Edesa is the issuer of the offering, raising approximately $25 million to fund operations and R&D. The dilutive capital raise may pressure the stock, but provides necessary funding for its clinical pipeline.
Aug 19, 2026 · 12 articles
Key Actions (2)
100 Edesa Biotech priced public offeringEdesa Biotech $25M Public Offering
30 Edesa Biotech granted underwriter option Guggenheim PartnersEdesa Biotech $25M Public Offering
ERGEN INTELLIGENCE
Track Edesa Biotech live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.